678 related articles for article (PubMed ID: 18383739)
1. [Croatian guidelines for use of eicosapentaenoic acid and megestrol acetate in cancer cachexia syndrome].
Krznarić Z; Juretić A; Samija M; Dintinjana RD; Vrdoljak E; Samarzija M; Kolacek S; Vrbanec D; Prgomet D; Ivkić M; Zelić M;
Lijec Vjesn; 2007 Dec; 129(12):381-6. PubMed ID: 18383739
[TBL] [Abstract][Full Text] [Related]
2. The effect of megestrol acetate on anorexia, weight loss and cachexia in cancer and AIDS patients (review).
Strang P
Anticancer Res; 1997; 17(1B):657-62. PubMed ID: 9066597
[TBL] [Abstract][Full Text] [Related]
3. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort.
Jatoi A; Rowland K; Loprinzi CL; Sloan JA; Dakhil SR; MacDonald N; Gagnon B; Novotny PJ; Mailliard JA; Bushey TI; Nair S; Christensen B;
J Clin Oncol; 2004 Jun; 22(12):2469-76. PubMed ID: 15197210
[TBL] [Abstract][Full Text] [Related]
4. Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate.
Mantovani G; Macciò A; Lai P; Massa E; Ghiani M; Santona MC
Semin Oncol; 1998 Apr; 25(2 Suppl 6):45-52. PubMed ID: 9625383
[TBL] [Abstract][Full Text] [Related]
5. [Current views on use of megestrol acetate in oncology practice].
Vyzula R
Vnitr Lek; 1997 Apr; 43(4):250-5. PubMed ID: 9601846
[TBL] [Abstract][Full Text] [Related]
6. Ten years of Croatian national guidelines for use of eicosapentaenoic acid and megestrol acetate in cancer cachexia syndrome - Evaluation of awareness and implementation among Croatian oncologists.
Krznaric Ž; Juretic A; Domislovic V; Barisic A; Kekez D; Vranesic Bender D
Clin Nutr ESPEN; 2019 Oct; 33():202-206. PubMed ID: 31451262
[TBL] [Abstract][Full Text] [Related]
7. [New strategies for tumor-related cachexia].
HNO; 1997 Nov; 45(11 Suppl):1-8. PubMed ID: 9509016
[No Abstract] [Full Text] [Related]
8. Treating malnutrition with megestrol acetate: literature review and review of our experience.
Karcic E; Philpot C; Morley JE
J Nutr Health Aging; 2002 May; 6(3):191-200. PubMed ID: 12152625
[TBL] [Abstract][Full Text] [Related]
9. Randomised phase III clinical trial of 5 different arms of treatment on 332 patients with cancer cachexia.
Mantovani G
Eur Rev Med Pharmacol Sci; 2010 Apr; 14(4):292-301. PubMed ID: 20496538
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of megestrol acetate in patients with advanced cancer: a randomized, double-blind, crossover study.
Bruera E; Ernst S; Hagen N; Spachynski K; Belzile M; Hanson J; Summers N; Brown B; Dulude H; Gallant G
Cancer Prev Control; 1998 Apr; 2(2):74-8. PubMed ID: 9765767
[TBL] [Abstract][Full Text] [Related]
11. Megestrol acetate for the treatment of anorexia-cachexia syndrome.
Berenstein EG; Ortiz Z
Cochrane Database Syst Rev; 2005 Apr; (2):CD004310. PubMed ID: 15846706
[TBL] [Abstract][Full Text] [Related]
12. Optimizing end points and outcomes in cancer-associated wasting.
Dahele M; Wall L
J Clin Oncol; 2005 Apr; 23(12):2871-2; author reply 2872-3. PubMed ID: 15838010
[No Abstract] [Full Text] [Related]
13. Clinical studies on the treatment of cancer cachexia with megestrol acetate plus thalidomide.
Wen HS; Li X; Cao YZ; Zhang CC; Yang F; Shi YM; Peng LM
Chemotherapy; 2012; 58(6):461-7. PubMed ID: 23406994
[TBL] [Abstract][Full Text] [Related]
14. Randomized phase III clinical trial of five different arms of treatment for patients with cancer cachexia: interim results.
Mantovani G; Macciò A; Madeddu C; Gramignano G; Serpe R; Massa E; Dessì M; Tanca FM; Sanna E; Deiana L; Panzone F; Contu P; Floris C
Nutrition; 2008 Apr; 24(4):305-13. PubMed ID: 18262758
[TBL] [Abstract][Full Text] [Related]
15. [Standards, Options and Recommendations (SOR) for the use of appetite stimulants in oncology. Work group. Federation of the French Cancer Centres (FNCLCC)].
Desport JC; Blanc-Vincent MP; Gory-Delabaere G; Bachmann P; Béal J; Benamouzig R; Colomb V; Kere D; Melchior JC; Nitenberg G; Raynard B; Scheiner S; Senesse P
Bull Cancer; 2000 Apr; 87(4):315-28. PubMed ID: 10827350
[TBL] [Abstract][Full Text] [Related]
16. Megestrol acetate: its impact on muscle protein metabolism supports its use in cancer cachexia.
Busquets S; Serpe R; Sirisi S; Toledo M; Coutinho J; Martínez R; Orpí M; López-Soriano FJ; Argilés JM
Clin Nutr; 2010 Dec; 29(6):733-7. PubMed ID: 20621398
[TBL] [Abstract][Full Text] [Related]
17. Palliative treatment of cancer anorexia with oral suspension of megestrol acetate.
Tomíska M; Tomisková M; Salajka F; Adam Z; Vorlícek J
Neoplasma; 2003; 50(3):227-33. PubMed ID: 12937858
[TBL] [Abstract][Full Text] [Related]
18. The cancer cachexia syndrome.
Puccio M; Nathanson L
Semin Oncol; 1997 Jun; 24(3):277-87. PubMed ID: 9208884
[TBL] [Abstract][Full Text] [Related]
19. Appetite stimulants: the unsolved truth.
Baron M
Health Care Food Nutr Focus; 2000 Jun; 16(10):5-7. PubMed ID: 11182996
[No Abstract] [Full Text] [Related]
20. Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia.
Vadell C; Seguí MA; Giménez-Arnau JM; Morales S; Cirera L; Bestit I; Batiste E; Blanco R; Jolis L; Boleda M; Antón I
Am J Clin Oncol; 1998 Aug; 21(4):347-51. PubMed ID: 9708631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
